# Subcutaneous Pharmacokinetic Evaluation of Monomeric Insulin and Lyumjev in Adults With Type 1 Diabetes

> **NCT07090824** · PHASE1 · RECRUITING · sponsor: **Stanford University** · enrollment: 20 (estimated)

## Conditions studied

- Diabetes Mellitus, Type 1
- Type 1 Diabetes Mellitus

## Interventions

- **DRUG:** Diluted Humalog U-200 Insulin
- **DRUG:** Diluted U-500 Humulin Insulin
- **DRUG:** Lyumjev U-100 Insulin
- **DIETARY_SUPPLEMENT:** Boost Mixed Meal Test

## Key facts

- **NCT ID:** NCT07090824
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-28
- **Primary completion:** 2026-07
- **Final completion:** 2026-10
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07090824

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07090824, "Subcutaneous Pharmacokinetic Evaluation of Monomeric Insulin and Lyumjev in Adults With Type 1 Diabetes". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07090824. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*